A detailed history of Alpha Family Trust transactions in Abb Vie Inc. stock. As of the latest transaction made, Alpha Family Trust holds 4,375 shares of ABBV stock, worth $863,975. This represents 0.44% of its overall portfolio holdings.

Number of Shares
4,375
Previous 4,375 -0.0%
Holding current value
$863,975
Previous $796,000 5.78%
% of portfolio
0.44%
Previous 0.48%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $72,240 - $81,359
525 Added 13.64%
4,375 $677,000
Q3 2023

Nov 02, 2023

BUY
$133.59 - $154.65 $514,321 - $595,402
3,850 New
3,850 $573,000
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $57,844 - $66,616
400 Added 11.13%
3,995 $636,000
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $497,224 - $596,302
3,595 New
3,595 $581,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $337,169 - $428,652
2,450 New
2,450 $375,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Alpha Family Trust Portfolio

Follow Alpha Family Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Family Trust, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Family Trust with notifications on news.